Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,793 total articles

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

aTyr Pharma provided an update indicating they expect a FDA response by mid-September 2026 regarding their submitted protocol for a planned global Phase 3 trial of efzofitimod in patients with moderate to severe pulmonary sarcoidosis. The trial aims to evaluate efficacy and safety over 54 weeks, with primary and secondary lung function endpoints, i…

Xos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the Field

Xos Hub Surpasses One Gigawatt-Hour of Energy Delivered in the Field

Xos, Inc. announced that its Xos Hub energy storage and charging system has surpassed one gigawatt-hour of cumulative energy delivered, demonstrating durability and reliability in continuous commercial operation since early 2025. This milestone supports the company's growth with expanded product versions, utility deployment orders, and entry into t…

STERIS to Present at the Morgan Stanley Healthcare Conference

STERIS to Present at the Morgan Stanley Healthcare Conference

STERIS plc, a global provider of healthcare and life science products focused on infection prevention, announced its participation in the Morgan Stanley Healthcare Conference where CEO Dan Carestio will present. The company highlighted the availability of a webcast and included a detailed cautionary statement regarding forward-looking statements an…

Cellectis Announces Participation in Upcoming Investor Conferences

Cellectis Announces Participation in Upcoming Investor Conferences

Cellectis, a clinical-stage biotech company specializing in gene editing and CAR T-cell therapies, announced its participation in several upcoming healthcare investor conferences across the US and Europe. Management will engage with investors and present updates on the company's developments and strategic direction, continuing to promote its pionee…

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Braveheart Bio to Participate in Cantor Global Healthcare Conference

Braveheart Bio, a clinical-stage biopharmaceutical company specializing in treatments for hypertrophic cardiomyopathy and other cardiovascular diseases, announced its participation in the Cantor Global Healthcare Conference. The company's management will engage in a fireside chat to discuss their lead product candidate, BHB-1893, an oral small-mole…

California Resources Corporation Completes Acquisition of Crimson

California Resources Corporation Completes Acquisition of Crimson

California Resources Corporation (NYSE: CRC) announced the completion of its $63 million all-cash acquisition of Crimson Midstream Holdings, LLC from CorEnergy Infrastructure Trust. Approved by the California Public Utilities Commission, this acquisition strengthens CRC's energy portfolio by adding midstream infrastructure to improve delivery effic…

United Community Banks, Inc. Announces Completion of Sale of Navitas Equipment Finance Business to Funds Managed by Wafra Inc.

United Community Banks, Inc. Announces Completion of Sale of Navitas Equipment Finance Business to Funds Managed by Wafra Inc.

United Community Banks, Inc. announced the completion of the sale of its Navitas equipment finance business to funds managed by Wafra Inc. for approximately $2 billion in cash, representing a 7% premium to the loan portfolio's par value. This transaction allows United Community Banks to concentrate on its core Southeastern relationship banking busi…

MYR Group Inc. to Attend Jefferies Renewables, Clean Energy, & Construction Conference in September

MYR Group Inc. to Attend Jefferies Renewables, Clean Energy, & Construction Conference in September

MYR Group Inc., a leading specialty electrical contractor serving the U.S. and Canadian markets, announced that its CEO and CFO will participate in the Jefferies Renewables, Clean Energy, & Construction investor conference virtually. The company offers services in electric utility infrastructure including transmission, distribution, clean energy pr…

Ryman Hospitality Properties, Inc. Closes Acquisition of Grande Lakes Orlando Resort and Updates 2026 Outlook

Ryman Hospitality Properties, Inc. Closes Acquisition of Grande Lakes Orlando Resort and Updates 2026 Outlook

Ryman Hospitality Properties, Inc. has finalized its acquisition of Grande Lakes Orlando Resort for approximately $1.38 billion, aiming to expand its presence in the upscale convention and group-oriented resort market. The acquisition is expected to bolster Ryman's market position in the largest U.S. meetings market and contribute positively to its…

Yatra Online, Inc. Board of Directors Unanimously Rejects Magna Holdings’ Unsolicited Partial Tender Offer

Yatra Online, Inc. Board of Directors Unanimously Rejects Magna Holdings’ Unsolicited Partial Tender Offer

Yatra Online, Inc.'s Board of Directors unanimously opposes Magna Holdings Ltd.'s unsolicited partial tender offer to acquire up to 31% of the company's shares at $1.10 per share, stating the offer substantially undervalues the company and presents significant risks to shareholders. The Board recommends shareholders reject the offer due to the unde…

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference on September 15

Sight Sciences, Inc., a US-based eyecare technology company specializing in minimally invasive and interventional treatments for eye diseases such as glaucoma and dry eye disease, announced it will present at the Morgan Stanley Global Healthcare Conference on September 15, 2026. The company will discuss its innovative OMNI®, SION®, and TearCare® su…

Sana Biotechnology to Present at September 2026 Investor Conferences

Sana Biotechnology to Present at September 2026 Investor Conferences

Sana Biotechnology, a NASDAQ-listed biotechnology company focused on engineered cell therapies, will present business updates and an overview at four major healthcare investor conferences in September 2026. Presentations will be webcast and include updates on the company's strategy, operations, and prospects. The company emphasizes its commitment t…

Greenlight Capital Re, Ltd. Announces New Director Appointments

Greenlight Capital Re, Ltd. Announces New Director Appointments

Greenlight Capital Re announced the appointments of John Welch and Ariel Warszawski as new independent directors to its board. These appointments are expected to bolster the company's leadership with broad expertise in reinsurance, underwriting, investment, and business strategy, supporting Greenlight Re's continued growth and innovation in the pro…

CAMP4 to Participate in Upcoming Investor Conferences

CAMP4 to Participate in Upcoming Investor Conferences

CAMP4 Therapeutics Corporation, a clinical-stage biopharmaceutical company focused on RNA-targeting therapeutics for genetic diseases, announced its participation in the Wells Fargo 21st Annual Healthcare Conference and the Cantor Global Healthcare Conference in September 2026. The company will present through meetings and a fireside chat, with web…

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences to Participate in Upcoming Investor Conferences

Cytek Biosciences, a Nasdaq-listed cell analysis solutions company, announced its participation in three major upcoming healthcare investor conferences in September 2026, including Wells Fargo, Morgan Stanley, and Deutsche Bank events. Company leadership will engage in meetings and a fireside chat to discuss business prospects and innovations. The …